Collaborative or competitive phase transformation processes in an additively manufactured-maraging steel M300
Journal of Materials Research and Technology · 2025-11 · 39 · 2686-2703
DOI: 10.1016/j.jmrt.2025.09.243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Research and Technology, 2025-11. Verfasst von Ana Santana und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Research Fund for Coal and Steel, Government of Spain Ministry of Universities, Office of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Research Fund for Coal and Steel
- Government of Spain Ministry of Universities
- Office of Science
- Oak Ridge National Laboratory
- European Commission
- U.S. Department of Energy
- Ministerio de Ciencia, Innovación y Universidades
Zitieren
APA
Santana, A., Eres-Castellanos, A., Królicka, A., Poplawsky, J. D., Clarke, A. J., Capdevila, C., & Caballero, F. G. (2025). Collaborative or competitive phase transformation processes in an additively manufactured-maraging steel M300. Journal of Materials Research and Technology, 39, 2686-2703. https://doi.org/10.1016/j.jmrt.2025.09.243
Vancouver
Santana A, Eres-Castellanos A, Królicka A, Poplawsky JD, Clarke AJ, Capdevila C, et al. Collaborative or competitive phase transformation processes in an additively manufactured-maraging steel M300. Journal of Materials Research and Technology. 2025;39:2686-2703. doi:10.1016/j.jmrt.2025.09.243
BibTeX
@article{Santana2025,
author = {Santana, Ana and Eres-Castellanos, Adriana and Królicka, Aleksandra and Poplawsky, Jonathan D. and Clarke, Amy J. and Capdevila, Carlos and Caballero, Francisca G.},
title = {Collaborative or competitive phase transformation processes in an additively manufactured-maraging steel M300},
journal = {Journal of Materials Research and Technology},
year = {2025},
volume = {39},
pages = {2686--2703},
doi = {10.1016/j.jmrt.2025.09.243}
}
EUVIMED